Regarding thyroid malignancies, we observed two cases: one of papillary thyroid carcinoma in a patient treated with interferon beta, and another of medullary thyroid carcinoma in a patient who had received interferon beta, teriflunomide, and ocrelizumab. The gene discussed is IFNB1; the disease is medullary thyroid gland carcinoma.